Hasan Jafri - Sep 18, 2023 Form 4 Insider Report for Aridis Pharmaceuticals, Inc. (ARDS)

Role
Chief Medical Officer
Signature
/s/ Hasan Jafri
Stock symbol
ARDS
Transactions as of
Sep 18, 2023
Transactions value $
$0
Form type
4
Date filed
9/19/2023, 04:05 PM
Previous filing
Jun 15, 2023
Next filing
Jun 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDS Stock Options Award $0 +20K +12.9% $0.00 175K Sep 18, 2023 Common Stock 20K $0.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the options vest on the date of grant and approximately 1,666 vest on a monthly basis thereafter for six months.